An observational study in patients who received nivolumab preoperatively for stage 1 non-small cell lung cancer considered as high-risk of relapse

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1060190007

Enrollment

Registered

2019-06-18

Start date

2019-07-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients enrolled and received nivolumab therapy in the POTENTIAL study. 2.Subjects who were fully informed beforehand about their participation in this observational study and agreed to participate in the study in writing.

Exclusion criteria

Exclusion criteria: 1.Patients who are limited, or predicted to be limited, for participation of this study by geographic or social factors during the study period.

Design outcomes

Primary

Measure	Time frame
overall survival	—

Secondary

Measure	Time frame
progression-free survival	—

Contacts

Public ContactYasuhiro Tsutani

Hiroshima University Hospital

yatsutani@msn.com+81-82-257-5869

Outcome results